Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 11 Mar 2024

Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound

in Thoracic Oncology

Hong Wei
Yichun Wang
Jinyao Li
Yanyan Wang
Longdi Lu
Jiawei Sun
Xiaolei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1352028

1,069 views
1 citation

Original Research

Published on 11 Mar 2024

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

in Thoracic Oncology

Miao Huang
Bing Liu
Xiang Li
Nan Li
Xin Yang
Yaqi Wang
Shanyuan Zhang
Fangliang Lu
Shaolei Li
Shi Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1367200

1,181 views

Editorial

Published on 11 Mar 2024

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

in Thoracic Oncology

Daniela de Totero
Emanuela Barisione
Enrico Clini

Frontiers in Oncology

doi 10.3389/fonc.2024.1389532

1,233 views

Systematic Review

Published on 08 Mar 2024

Application of three-dimensional technology in video-assisted thoracoscopic surgery sublobectomy

in Thoracic Oncology

Xinyu Zhang
Di Yang
Linqian Li
Jianing Wang
Si Liang
Peng Li
Zhe Han
Xiaodong Wang
Ke Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1280075

2,147 views
1 citation

Original Research

Published on 08 Mar 2024

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

in Thoracic Oncology

Shirish M. Gadgeel
Pragya Rai
Srinivas Annavarapu
Sartaj Alam
Jerome H. Goldschmidt
Howard (Jack) West
Melissa Santorelli
Renata Eiras Martins

Frontiers in Oncology

doi 10.3389/fonc.2024.1298603

3,322 views

Review

Published on 07 Mar 2024

Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

in Thoracic Oncology

Yunbin Li
Xiaosong Li
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1360638

2,816 views
3 citations

Study Protocol

Published on 07 Mar 2024

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial

in Thoracic Oncology

Weigang Dong
Yan Yin
Bin Liu
Yan Jiang
Lei Wang
Dongsheng Shi
Jianwen Qin

Frontiers in Oncology

doi 10.3389/fonc.2024.1179232

2,276 views
2 citations

Original Research

Published on 05 Mar 2024

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

in Thoracic Oncology

Xiao Li
Zhen Gao
Haixiao Diao
Chenran Guo
Yue Yu
Shang Liu
Zhen Feng
Zhongmin Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1326626

1,600 views
2 citations

Case Report

Published on 01 Mar 2024

Case report: Primary pulmonary low grade fibromyxoid sarcoma progressing to dedifferentiation: probably due to TP53 driver mutation

in Thoracic Oncology

Jiawen Zhang
Haisheng Fang
Xiaomei Zhu
Chenchen Yao
Qinhe Fan
Qixing Gong

Frontiers in Oncology

doi 10.3389/fonc.2024.1329264

1,654 views
1 citation

Case Report

Published on 27 Feb 2024

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report

in Thoracic Oncology

Zhiming Wu
Zelin Zhang
Dongdong Zhang
Zengyan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1357230

1,487 views
3 citations

Case Report

Published on 23 Feb 2024

Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy

in Thoracic Oncology

Yukiko Nemoto
Koji Kuroda
Rintaro Oyama
Masataka Mori
Shohei Shimajiri
Fumihiro Tanaka

Frontiers in Oncology

doi 10.3389/fonc.2024.1290757

1,698 views
3 citations

Systematic Review

Published on 22 Feb 2024

Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials

in Thoracic Oncology

Anping Yu
Feng Fu
Xiongying Li
Mengxin Wu
Meijian Yu
Wenxiong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1351359

4,190 views
2 citations

Case Report

Published on 15 Feb 2024

Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy

in Thoracic Oncology

Quanqing Li
Guangxin Zhang
Hao Yang
Jindong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1329152

1,322 views

Case Report

Published on 14 Feb 2024

RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case report

in Thoracic Oncology

Reza Pishdad
Peter B. Illei
Christopher D. Gocke
Douglas W. Ball

Frontiers in Oncology

doi 10.3389/fonc.2024.1360492

1,784 views
4 citations

Review

Published on 13 Feb 2024

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

in Thoracic Oncology

Namariq Abbaker
Fabrizio Minervini
Angelo Guttadauro
Piergiorgio Solli
Ugo Cioffi
Marco Scarci

Frontiers in Oncology

doi 10.3389/fonc.2024.1347464

4,246 views
7 citations

Case Report

Published on 13 Feb 2024

Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib

in Thoracic Oncology

Nana Huang
Tianhao Qu
Chunxia Zhang
Jia Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1269148

2,179 views
2 citations